The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001

Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001

Acute Hepatic Encephalopathy with Diffuse Cortical Lesions
Neuroradiology 43:551-554, Arnold, S.M.,et al, 2001

Is Fluid-attenuated Inversion Recovery MRI More Sensitive Than Conventional MRI for Hypoglycemic Brain Injury
Neurol 55:1064-1065, Bakshi,R.,et al, 2000

Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000

Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000

Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000

Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000

Agranulocytosis Associated with Lamotrigine
BMJ 318:1179, DeCamargo,O.A.K., 1999

Muscle Pain after Exercise
Lancet 353:1062, Nielen,C.&Mazzone,P., 1999

Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly
Arch Int Med 159:38-44, Bots,M.L.,et al, 1999

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Medical Complications in Long-Term Survivors with X-Linked Myotubular Myopathy
J Pediatr 134:206-214, Herman,G.E.,et al,, 1999

Riluzole-Induced Pancreatitis
Neurol 52:892-893, Drory,V.E.,et al, 1999

Hemiballismus-Hemochorea in Older Diabetic Women:A Clinical Syndrome with MRI Correlation
Neurol 52:646-648, Lee,B-C.,et al, 1999

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Disorientation and Vertebral Fractures
Lancet 353:1848, McConnaughey,D.,et al, 1999

Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999

A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular Cancer
NEJM 340:1788-1795,1831, Voltz,R.,et al, 1999

Homocyst(e)ine and Risk of Cerebral Infarcdtion in a Biracial Population, The Stroke Prevention in Young Women Study
Stroke 30:1554-1560, Kittner,S.J.,et al, 1999

Amyloid Myopathy:An Underdiagnosed Entity
Ann Neurol 43:719-728, Spuler,S.,et al, 1999

Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons:The Framingham Study
Ann Int Med 131:352-355, Bostom,A.G.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Tasmar (tolcapone) Labeling Revisions of Package Insert
Roche Laboratories, , 1998

Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998

Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

Interferon Treatment for Multiple Sclerosis:Autoimmune Complications May be Lethal
Neurol 50:570-571, Durelli,L.,et al, 1998

Diagnosis of Creutzfeldt-Jakob Disease by Measurement of S100 Protein in Serum:Case-Control Study
BMJ 316:577-581, 5631998., Otto,M.,et al, 1998

Prognosis of patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy
Am J Med 104:232-237, Rajkumar,S.V.,et al, 1998

Consequences of the Delayed Diagnosis of Ataxia-Telangiectasia
Pediatrics 102:98-100, Cabana,M.D.,et al, 1998

Wobbly Handwriting
Lancet 351:336, Rosario,M.A.F.,et al, 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

Postpartum Coma
Lancet 351:1700, McCormack,G.,et al, 1998

Cytologically Negative Carcinomatous Meningitis:Usefulness of CSF Biochemical Markers
Neurol 50:1173-1175, Chamberlain,M.C., 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Neuropathies Associated with Paraproteinemia
NEJM 338:1601-1607, Ropper,A.H.&Gorson,K.C., 1998

The Value of Interphase Cytogenetics in Cytology for the Diagnosis of Leptomeningeal Metastases
Neurol 51:906-908, Van Oostengrugge,R.J.,et al, 1998

The Importance of Formal Serum Iron Studies in the Assessment of Restless Legs Syndrome
Neurol 51:912, Aul,E.A.,et al, 1998

Lamotrigine-Associated Anticonvulsant Hypersentivitiy Syndrome
Neurol 51:1171-1175, Schlienger,R.G.,et al, 1998

Neuroimagen en la hipoglucemia
Rev Neurol 26:774-776, Cubo,E.,et al, 1998

Permanent Visual Loss and Cerebrovascular Accidents in Giant Cell Arteritis: Predictors and Response to Treatment
Arthritis Rheum 41:1497-1504, Gonzalez-Gay,M.,et al, 1998

Hepatic Encephalopathy and Ascites
Lancet 350:1309-1315, Jalan,R.&Hayes,P.C., 1997

Specific Changes in Human Brain After Hypoglycemic Injury
Stroke 28:584-587, Fujioka,M.,et al, 1997

CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997

Neurological Disturbances Due to Filgrastim
Lancet 349:402-403, Schrijvers,D.,et al, 1997

Serum Creatinine Concentration and Risk of Cardiovascular Disease
Stroke 28:557-563, Wannamethee,S.G.,et al, 1997

Clinicopath Conf
Genetic Hemochromatosis, Micronodular Cirrhosis of Liver, Case 10-1997, NEJM 336:939-94797., , 1997